Low Dose Naltrexone Weight Loss

Alcoholism is an issue which afflicts over 14 million Americans, almost 8% from the population in the United States. The majority of alcohol rehabilitation programs in use today possess a low success rate, because of this many people have ventured into medications in order to limit or stop their drinking problem. Two types of medications are used in the treatment of alcoholics, Aversive Medications and Anticraving Medications.

Using two separate drugs to shed weight can be very effective you can find combinations before the FDA now awaiting approval. When dealing with weight loss and the individuals who go through it one should err along the side of caution and allow FDA do its job and demand some investigation be done in order that the public knows the side effects and risks of the medications before we take them. Keep in mind that drug companies are in business to generate income and that they would say everything to keep people on his or her medications.

Researchers found out that participants using this drug for any year, lost excess weight within one month and have kept the load off throughout the 56 weeks in the study. Contrave is often a combination from the drugs naltrexone and bupropion, which usually reflect a fresh trend of weight-loss drugs which are made up of multiple active ingredient, that might make them far better and safer.

Combo-pilling is the newest fad or in addition to this the newest into the future under scrutiny and thus it is just more publicly known lately, comb-pilling for losing weight has been around since the eighties. The biggest reason that by using a combination of pills is now popular is the fact that by right now there are no long term prescription weightloss pills that have been approved by the FDA apart from orlistat. The truly disturbing part is doctors are prescribing these combinations of medications although some people might of the combinations have been rejected or have yet to be approved by the FDA.

Seizures can be a side effect with Contrave and really should not be taken in people who have seizure disorders. The drug also can raise hypertension and heart rate, and mustn’t be used in individuals with a history of cardiac arrest or stroke in the last six months. Blood pressure and pulse should also be measured before beginning the drug and throughout therapy with the drug.

The FDA also warned that Contrave can raise blood pressure and heart rate and must not used in patients with uncontrolled high blood pressure levels, as well as by you aren’t heart-related and cerebrovascular (blood vessel dysfunction impacting the brain) disease. Patients having a history of heart attack or stroke in the last six months, life-threatening arrhythmias, or congestive heart failure were excluded through the clinical trials. Those taking Contrave needs to have their heart-rate and pulse monitored regularly. In addition, because the compound includes bupropion, Contrave comes having a boxed warning to alert medical researchers and patients for the increased chance of suicidal thoughts and behaviors related to antidepressant drugs. The warning also notes that serious neuropsychiatric events happen to be reported in patients taking bupropion for stop smoking.

Most of the combinations which can be used to enhance weight loss involve an amphetamine as well as an antidepressant. Phentermine and Prozac really are a popular combination that were around for some time, and even though it has been around stuffed to truly combine the two and try to get FDA approval to market it as a weight reduction pill. Right there should raise some red flags if the greedy pharmaceutical companies should not be involved in combining medications and selling them something should be wrong while using combination. In fairness there is one weight loss combination pill that is in front of the FDA now Contrave?which couples naltrexone, used to treat alcohol and drug addiction, using the antidepressant bupropion (Wellbutrin, Zyban) it’s been given the go ahead to move forward by an FDA advisory committee, but by yet will not be approved.

Published
Categorized as Journal